Trump plans 200% tariff on alternative medicines

U.S. President Donald Trump announced that he will impose tariffs on imported generic drugs starting in mid-2028, aiming to encourage pharmaceutical companies to manufacture them domestically. Generic drugs will remain exempt from tariffs until August 2028, after which a 100% tariff will be applied for one year, escalating to 200% thereafter, in an effort to incentivize companies to shift production to the United States. He also threatened sanctions against companies that choose not to establish facilities within the U.S., without specifying the nature of the sanctions or the legal basis. This move is expected to impact the global pharmaceutical market and increase pressure on foreign manufacturing companies.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل